{"name":"C2N Diagnostics","slug":"c2n-diagnostics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2026-03-19","type":"trial","source":"Business Wire","summary":"C2N Diagnostics Highlights First Use of Its eMTBR-tau243 Plasma Assay in Evoke/Evoke+ Phase 3 Dataset for Prediction of Cognitive and Functional Decline in Patients With Early Symptomatic Alzheimer’s ","headline":"C2N Diagnostics Highlights First Use of Its eMTBR-tau243 Plasma Assay in Evoke/Evoke+ Phase 3 Dataset for Prediction of ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-16","type":"deal","source":"Indian Pharma Post","summary":"C2N Diagnostics expands Alzheimer’s blood test to South Korea via BeauBrain partnership - Indian Pharma Post","headline":"C2N Diagnostics expands Alzheimer’s blood test to South Korea via BeauBrain partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5ZTlQ0eXFJVVZ0V0gxSVlsTUh5ODhvMXRtN3c2eERwemp4V0pEblBxeG9obkV0TDV4UmpFYWZDX1hlSlFBNnc0U3FiLVRrMy1fQXlqbXJKZThBaXc5M3NTcHoybDZ1U2kyMlRmVFlB?oc=5","date":"2025-10-17","type":"pipeline","source":"KED Global","summary":"Samsung to invest $110 mn in Grail to bring early-cancer test to Asia - KED Global","headline":"Samsung to invest $110 mn in Grail to bring early-cancer test to Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNckZJcWNLVmlrZl9sY0FkQnZBYmpFVTdwN3NkS2RQVlRmVktuUVhpU0s2REFSaVBaQnFhNHZkWXFubWxhQUkxTFVBNkFWQy1uX1VhQ3RROTd1X05mSTdqYjgwRHdMNXNnVUFweGYtNHpER2VlMmM1NTBaeWJjMUpTMlpEZWxrQ0pNYTB4RFpHQWpKY0FKZHh2Rnh5VnJfZ3BJM2NsdDJmTGpIZ0tsVUdRTVNUN3ZwT1RiYUVjTEgzUQ?oc=5","date":"2025-09-18","type":"pipeline","source":"Clinical Lab Products","summary":"C2N Diagnostics Triples St. Louis Operations with New 82,000-Square-Foot Facility - Clinical Lab Products","headline":"C2N Diagnostics Triples St. Louis Operations with New 82,000-Square-Foot Facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOX292SGVlQkpfcG1STE1YTEVuRXdmWk1yOXBEeHpLVEhSbEkteDQ5bTRQMXFFU2w0eWoydE5ZRVh2RVBBQlZFQklQa2V0V213M2VuZzBVUVhTUC0xMUdaMy1yZ2tTaC1XeG1kWm0zNDhPOE1Pc3FfTkFjVjNHZ1dEcE9idjBFSlZMakNDZmZ1N2ZObkFkQWc5WmxHQkRIR1ZaSXA4S2hQampESEZDSW1hTElYUHZYYlZXUGJtU3VralpFYk9BUVBJ?oc=5","date":"2025-05-16","type":"regulatory","source":"Reuters","summary":"US FDA clears first blood test for Alzheimer's detection - Reuters","headline":"US FDA clears first blood test for Alzheimer's detection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOTzJkcUcyWUtWOVM1SFFocjBxSXhnd1lHS1JiaEotT2QwdkoxVmRTWERXa3BycHlpMm1fRUlSOHN1cm9lRmFPNExxSjB5N2lXMHJITDFzYnBUMV9wLUdUVjI4UjEtenFoYzY2TEJBZ25oOVY4RTRLQWw4ajFJdWJNWGVkRmdkVXppSXFtNQ?oc=5","date":"2025-03-14","type":"pipeline","source":"Contract Pharma","summary":"Samsung Invests $10M in CS2 Diagnostics - Contract Pharma","headline":"Samsung Invests $10M in CS2 Diagnostics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOZm4tTDhKajl2Q1RWNk1uOW1ydmFDcEdQekZBRC0tMnZxY1NRRmtVd01IQ2RVejhvcWJuRjN0YkRsSTlwMUJkc05wLU90Sk01RFN0dmNOMDU4VU9mM1FhZnlkZUxjVkdTNGViVGR1T1FZZnRMOXZjQ3pzZGpoZUF5UHRGY3BzQ2U4YzY1N09nUmU4NEx1QXk5LU9fMzZKZVJJUWlXM1FVdFNVX0Y5bUpNMlN1cjVxQm1ickxOUmdLdHZRaUVJUVhLeW5fVEtZLXJYcElqTkxnbw?oc=5","date":"2025-03-14","type":"pipeline","source":"BioPharma APAC","summary":"C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing - BioPharma APAC","headline":"C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxObTMzeWRQX0VWWmJ5ZUpVYVREMDR6a05hcWNNRXpXMnFSTEVjdTF3b1RVSnVsTGtLbzktdUFoZHI4SDZWaC13LWl6emg5RndBN0lZZEhZQmVlbHNjNHVOb3FhNU1LUVg1MWZlNWZHTGRtOHVBM1h3OUhiNnJ2bFkxN3Y0VlFiTTdrZXAyY2I4ZUwydkRNNlhJQXI1cXZpZw?oc=5","date":"2025-03-14","type":"pipeline","source":"Medical Device Network","summary":"C2N Diagnostics lands $10m cash injection from Samsung - Medical Device Network","headline":"C2N Diagnostics lands $10m cash injection from Samsung","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOa0ctbW1jUWt6QnlSSkg2ZUtReFJiT2xGZ1NfcGUycE9PQjI5dDBUeHd6VF9qemoxeXduMVVoT0hBNG1IREZ5Vk5uOXNTbkFvbG5sY0pMSkpkOFZvQnozQ1FxdFE4MGRIb1N6ZHdkZElWek1mR3E3eFFhS196UldkU05vMkNiREYzb25FbTBxZXZhclNaZjdkUlBzcmx2azluZnZfTTR0THZqUjBFVEQwdWNQeHU2eFpNU2QtVXFB?oc=5","date":"2025-03-11","type":"pipeline","source":"Medical Product Outsourcing","summary":"C2N Diagnostics Awarded U.K. Medical Device Certification for Alzheimer’s Blood Test - Medical Product Outsourcing","headline":"C2N Diagnostics Awarded U.K. Medical Device Certification for Alzheimer’s Blood Test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxNZkdWVl9KS3lERm1fcFNOcEZKMTF5TkIzNlRxUzliZGM5dTN3SWtqeW9vWEVtVnViaXpCVkIydUNFYWhTbGkzOVZaVm4zclJXS0NCR3RFTDJTNkc3QUhoMmg1TEpYdUduMXVFakZlTVpDMXNMQXBHQUpJQWxOaENOTjZ5Qmk1b2d6YkFfUE9ZREV4bjZHelA3RTZVV3Q1Tnota2VBanEtS0xxWXFYaE1XelV2WFI1cTlnbE1ONnZsM202aVpCZlh0SjJ0ZEsyeFdSejMtX3VhWUNKdGtSamlIWXJCSkU3SmxOYUhSZXpTSXRFcXNkUXd1cll4bmhfZkNaa1hTM2JfdHFtYUluNWJKeVNVd19GYWwtV0FFeXctbmlLRENMc19Fdw?oc=5","date":"2024-10-01","type":"pipeline","source":"BioSpace","summary":"C2N Diagnostics Receives $15 Million Program Related Investment from GHR Foundation to Develop Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease - BioSpace","headline":"C2N Diagnostics Receives $15 Million Program Related Investment from GHR Foundation to Develop Tau Tangle Pathology Test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOdElsdlBoNUl5aS1rZDFRUGNDVC1BZ0tHSXh2bFU5WVFoMTNMeEpZazZGNnFpeU9tOE5SSnlHc0oxd2JuSmNRMlpGOFNudjV6OGhoRW1VMWFNYmVTcE9YalVSallzUFMzdnh0WU8xdFVlRG0zMmJQdFM1dUx3NmpiLUM4Z21zaXQ0T2liU0l5a3djWHdXNGhGU2lEbk9WUVBSemcxUWdNTlpYT2hPV0JCTmZTV2pjdjlEQ01fVVQyQWJwQk5aUmdxbEliTnk1M2NvcFlhYkZfNm9FUkNOLXdxRXNDX000ODBHOXFQaVp5MVpmSHpWQVV1Uw?oc=5","date":"2024-08-16","type":"trial","source":"Dark Daily","summary":"In Vitro Diagnostics Companies Race to Develop Blood-based Tests for Alzheimer’s Disease, Data Suggest a Worldwide Growing Market - Dark Daily","headline":"In Vitro Diagnostics Companies Race to Develop Blood-based Tests for Alzheimer’s Disease, Data Suggest a Worldwide Growi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQcUZpZHdSbUxPLVEtbVA4T2dNZ2Nyd3haWDNwQ3Z1Y19qR3pUY0VFUGszblZYYmtWZ0RLT2xvZXBVallqNHlWWklXWVZCWURBSTJJWFBOTFBYaFFxOGNkRm8wc3U3TEtlNkE2NGlPOUY1bVVodlZJZ0pVMXZSU1RLQmZSY2d5cnVMSEpTZ0VRaHNRRlRzMEt2clZmRzlzaWVFekRoLUppRm5McmJ0MFhtbQ?oc=5","date":"2024-03-06","type":"pipeline","source":"Fierce Biotech","summary":"Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests - Fierce Biotech","headline":"Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}